Inactive Instrument
RAMM Pharma Corp. Share Price OTC Markets
Stocks
RAMMF
CA75150G1046
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.79M 1.28M 1.1M 1.01M 953K 120M 1.81M 12M 4.67M 59.13M 4.79M 4.69M 205M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.07M 761K 656K 603K 568K 71.81M 1.08M 7.15M 2.78M 35.24M 2.86M 2.79M 122M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -76.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 08/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 30/09/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 30/09/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 30/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -76.29% | -92.33% | - | - | 1.28M | ||
| -0.94% | -2.14% | +40.54% | +148.38% | 992B | ||
| -0.42% | -1.80% | +53.69% | +42.60% | 564B | ||
| -0.56% | -1.65% | +19.27% | +59.57% | 391B | ||
| -1.18% | +0.68% | +24.66% | +16.53% | 330B | ||
| +1.42% | +0.06% | +26.36% | +14.29% | 280B | ||
| +1.09% | +1.65% | +26.61% | +33.32% | 279B | ||
| +1.87% | +0.87% | -41.49% | -48.26% | 196B | ||
| -1.78% | +1.16% | +17.79% | +48.77% | 184B | ||
| -1.40% | +3.27% | +16.16% | +59.08% | 156B | ||
| Average | -7.82% | +0.41% | +20.40% | +41.59% | 374.58B | |
| Weighted average by Cap. | -0.37% | -0.49% | +29.25% | +65.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.1M 2.67M 2.45M 2.31M 292M 4.38M 29.09M 11.33M 143M 11.62M 11.37M 496M | 3.36M 2.4M 2.07M 1.9M 1.79M 226M 3.39M 22.52M 8.77M 111M 8.99M 8.8M 384M |
| Net income | -16.5M -11.76M -10.15M -9.33M -8.78M -1.11B -16.64M -111M -43.05M -545M -44.15M -43.21M -1.88B | -8.91M -6.35M -5.48M -5.04M -4.74M -599M -8.98M -59.7M -23.24M -294M -23.84M -23.33M -1.02B |
| Net Debt | -626K -446K -385K -354K -333K -42.1M -631K -4.19M -1.63M -20.66M -1.67M -1.64M -71.47M | -723K -516K -445K -409K -385K -48.67M -730K -4.85M -1.89M -23.89M -1.94M -1.89M -82.64M |
Employees
-
Sector
Pharmaceuticals
















